PK of Serelaxin in Severe Renal Impairment and ESRD

NCT01875523 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Renal Failure, Chronic
End-Stage Renal Disease

Interventions

DRUG: Serelaxin

Sponsor

Novartis Pharmaceuticals